We are live on ! Find out more
CPIX icon

Cumberland Pharmaceuticals
CPIX

23 hedge funds and large institutions have $7.43M invested in Cumberland Pharmaceuticals in 2021 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 5 increasing their positions, 7 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.93% less ownership

Funds ownership: 19.53% → 18.6% (-0.93%)

11% less capital invested

Capital invested by funds: $8.36M → $7.43M (-$932K)

18% less funds holding

Funds holding: 28 → 23 (-5)

29% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 7

83% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 6

Holders
23
Holders Change
-5
Holders Change %
-17.86%
% of All Funds
0.4%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
5
Reduced
7
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$35.7K
2
BCM
Bridgeway Capital Management
Texas
+$22.6K
3
BAM
Berkshire Asset Management
Pennsylvania
+$15.9K
4
TRCT
Tower Research Capital (TRC)
New York
+$11.4K
5
UBS Group
UBS Group
Switzerland
+$4.36K

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$187K
2
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$175K
3
Renaissance Technologies
Renaissance Technologies
New York
-$110K
4
AI
Ariel Investments
Illinois
-$34K
5
Arrowstreet Capital
Arrowstreet Capital
Massachusetts
-$30K
Name Holding Trade Value Shares
Change 		Change in
Stake
Dimensional Fund Advisors
1
Dimensional Fund Advisors
Texas
$1.88M -$175K -58,846 -8%
Renaissance Technologies
2
Renaissance Technologies
New York
$1.78M -$110K -36,899 -5%
Vanguard Group
3
Vanguard Group
Pennsylvania
$1.05M – – –
BlackRock
4
BlackRock
New York
$892K -$187K -62,973 -16%
BAM
5
Berkshire Asset Management
Pennsylvania
$472K +$15.9K +5,355 +3%
BCM
6
Bridgeway Capital Management
Texas
$435K +$22.6K +7,600 +5%
Acadian Asset Management
7
Acadian Asset Management
Massachusetts
$429K -$18.4K -6,189 -4%
Geode Capital Management
8
Geode Capital Management
Massachusetts
$139K – – –
SFP
9
Sterling Financial Planning
New Jersey
$59K – – –
Northern Trust
10
Northern Trust
Illinois
$55K – – –
Bank of New York Mellon
11
Bank of New York Mellon
New York
$53K – – –
UCFA
12
United Capital Financial Advisors
Texas
$44K – – –
PPA
13
Parametric Portfolio Associates
Washington
$35K -$1.25K -420 -3%
Citadel Advisors
14
Citadel Advisors
Florida
$32K +$35.7K +12,021 New
Cambridge Investment Research Advisors
15
Cambridge Investment Research Advisors
Iowa
$27K – – –
Russell Investments Group
16
Russell Investments Group
United Kingdom
$13K – – –
TRCT
17
Tower Research Capital (TRC)
New York
$13K +$11.4K +3,834 +492%
OC
18
Oakworth Capital
Alabama
$8K – – –
Morgan Stanley
19
Morgan Stanley
New York
$8K +$36 +12 +0.4%
UBS Group
20
UBS Group
Switzerland
$5K +$4.36K +1,468 +316%
AI
21
Ariel Investments
Illinois
– -$34K -12,033 Closed
Arrowstreet Capital
22
Arrowstreet Capital
Massachusetts
– -$30K -10,700 Closed
California Public Employees Retirement System
23
California Public Employees Retirement System
California
– -$29K -10,205 Closed
Wells Fargo
24
Wells Fargo
California
– -$5.95K -2,003 -97%
Osaic Holdings
25
Osaic Holdings
Arizona
– -$2K -730 Closed
1
2

CPIX Hedge Fund Activity: Q3 2021 in Review

23 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Cumberland Pharmaceuticals (CPIX) for Q3 2021, worth a combined $7.43M — down 11% from $8.36M a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of CPIX and 1 opened new positions — a net loss of 5 holders — while 7 trimmed existing stakes and 5 added.

The largest buyer was Citadel Advisors, opening a new position worth an estimated $35.7K. The largest seller was BlackRock, cutting an estimated $187K.

  • 23 institutional investors held Cumberland Pharmaceuticals (CPIX) as of Q3 2021, down from 28 in Q2 2021.
  • Funds reported $7.43M of Cumberland Pharmaceuticals stock for Q3 2021, down 11% quarter-over-quarter.
  • 1 fund opened new Cumberland Pharmaceuticals positions in Q3 2021 and 6 closed out, a net change of -5 holders.
  • The largest Cumberland Pharmaceuticals buyer in Q3 2021 was Citadel Advisors, an estimated $35.7K added.
  • The largest Cumberland Pharmaceuticals seller in Q3 2021 was BlackRock, an estimated $187K sold.

Based on aggregated 13F filings for Q3 2021.